SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Peptech Limited (ASX: PTD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Angelo Ferraro who wrote ()12/9/1998 5:19:00 PM
From: Angelo Ferraro  Read Replies (1) of 5
 
the following may explain the recent rise in the stock:

Peptech Limited was today advised that its key patent covering its
second-generation long acting implant technology had been allowed by
the USA Patent Office.

The full patent will be issued to Peptech Limited upon the completion
of formal documents and the payment of patent costs which the Company
is required to complete by February 17, 1999.

The granting of patents for the second-generation implant is a
significant milestone in the Company's commercial development of long
acting peptide delivery vehicles.

As announced in June 1998 the Company sees a significant market for
these products in reversible contraceptive management in companion
animals, for use in population and behavioural control of other
species and for the treatment of human diseases particularly prostate
and breast cancer and, some gynaecological disorders in women of
childbearing age.

Dr M Cohen
EXECUTIVE CHAIRMAN
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News